Anzeige
Mehr »
Login
Dienstag, 11.02.2025 Börsentäglich über 12.000 News von 685 internationalen Medien
US-Biotech-Firma sorgt für Furore - steckt hier die Zukunft der Krebsheilung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
777 Leser
Artikel bewerten:
(2)

Gilead Sciences: Gilead Pays Tribute to Patient Advocacy Work: Cara's Story

Finanznachrichten News

NORTHAMPTON, MA / ACCESSWIRE / January 10, 2024 / Gilead Sciences:

When employees at Gilead's recently opened New Jersey office need a place to meet, the "Cara" conference room is one such place they gather. Given the room's namesake, it's especially fitting when the topic at hand is the company's oncology work.

A Pennsylvania mother of two young children, Cara was diagnosed with triple-negative breast cancer in 2018. She learned the following year that it had metastasized to her brain. But Cara says she isn't just surviving with metastatic triple-negative breast cancer - she's thriving and using her diagnosis as a way to help others.

After developing a passion for patient advocacy, Cara became president of 412Thrive, a Pittsburgh-based nonprofit that provides care packages for breast cancer patients as they navigate challenges like chemotherapy and radiation.

"The best thing from this whole diagnosis is that I'm able to volunteer my time to help others," says Cara.

The room in the Parsippany, New Jersey office was named after Cara to honor her perseverance and commitment to helping others. Each conference room on the two floors was named after a patient or advocate - serving as a visual reminder for Gilead employees of the communities they serve.

"It's such an honor because I feel like I've done some great advocacy work," says Cara. "It makes this journey so much more to know that I'm making a difference."

Watch the video above to see Cara's full story.

Originally published by Gilead Sciences

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

Contact Info:

Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com

SOURCE: Gilead Sciences



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Diesen Artikel auf Deutsch lesen
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.